Researchers have unveiled a groundbreaking 'metal detector' algorithm, PRRDetect, which could revolutionise cancer treatment by

‘Truly game-changing’ test can diagnose disease to a very high level of accuracy and identify aggression and sub-type

Explore new publication from the OMF Melbourne ME/CFS Collaboration: Discriminating ME/CFS and Comorbid Conditions Using NMR Metabolomics in UK Biobank.

Despite questions around stagnation, experts argue that cell and gene therapies are evolving rapidly –driven by innovation in manufacturing, decentralisation, and targeted delivery. Nicole Raleigh gat...